Pharmaids Pharma

{
  "main_header": {
    "sid": 799751,
    "name": "Pharmaids Pharma",
    "stock_name": "Pharmaids Pharma",
    "full_name": "Pharmaids Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/pharmaids-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.69",
    "chg": 0.51,
    "chgp": "1.88%",
    "dir": 1,
    "prev_price": "27.18",
    "mcapval": "97.66 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524572,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE117D01018",
    "curr_date": "Jun 04, 10:09 AM",
    "curr_time": "10:10 AM",
    "last_traded_at": "Jun 04, 10:09 AM IST",
    "bse_nse_vol": "243 ",
    "exc_status": "Active",
    "traded_date": "Jun 04, 2026",
    "traded_date_str": "2026 06 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/pharmaids-pharma-799751-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4033580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_mojoScore_4033580.png",
        "date": "2026-06-03 10:10:33",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Are Pharmaids Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-pharmaids-pharmaceuticals-ltd-latest-results-good-or-bad-4032438",
        "imagepath": "",
        "date": "2026-06-02 19:33:55",
        "description": "Pharmaids Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture of revenue growth juxtaposed against ongoing operational challenges. The company reported net sales of ₹7.18 crores, reflecting a 32.23% sequential increase from ₹5.43 crores in Q3 FY26 and a significant 50.52% rise year-on-year from ₹4.77 crores in Q4 FY25. However, this topline growth has not translated into profitability, as the company continues to face substantial net losses, with a consolidated net loss of ₹1.81 crores in Q4 FY26, which is a reduction from previous quarters but still indicative of ongoing financial distress.\n\nThe operating margin for the quarter was recorded at -4.74%, an improvement from -46.04% in Q3 FY26, yet it remains firmly in negative territory. This suggests that while there has been some operational progress, the company is still grappling with structural inefficiencies that hinder i..."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 25.6 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/pharmaids-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs256-4026324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_priceRelatedfactors_4026324.png",
        "date": "2026-06-01 10:35:26",
        "description": "A sharp decline of 15.62% in intraday trading dragged Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 25.6 on 1 Jun 2026, extending its downward trajectory amid persistent selling pressure."
      },
      {
        "title": "Pharmaids Pharmaceuticals Q4 FY26: Mounting Losses Despite Revenue Growth Signal Deep Operational Crisis",
        "link": "https://www.marketsmojo.com/news/result-analysis/pharmaids-pharmaceuticals-q4-fy26-mounting-losses-despite-revenue-growth-signal-deep-operational-crisis-4031013",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/PharmaidsPharma_quaterlyResult_4031013.png",
        "date": "2026-05-30 16:47:24",
        "description": "Pharmaids Pharmaceuticals Ltd., a Hyderabad-based contract research and manufacturing services company, reported its Q4 FY26 results that reveal a troubling paradox: robust revenue growth coupled with deteriorating profitability. The micro-cap pharmaceutical firm posted a consolidated net loss of ₹1.81 crores for the March 2026 quarter, marking a 27.02% sequential decline and a 54.06% year-on-year deterioration, even as net sales surged 50.52% YoY to ₹7.18 crores."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-4004853",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PharmaidsPharma_mojoScore_4004853.png",
        "date": "2026-05-22 10:10:58",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3985409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PharmaidsPharma_mojoScore_3985409.png",
        "date": "2026-05-11 10:10:28",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3968067",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3968067.png",
        "date": "2026-04-29 10:10:36",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3952050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3952050.png",
        "date": "2026-04-18 10:10:14",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Pharmaids Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/pharmaids-pharmaceuticals-ltd-is-rated-strong-sell-3935178",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PharmaidsPharma_mojoScore_3935178.png",
        "date": "2026-04-07 10:10:02",
        "description": "Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 122,
    "sid": "799751",
    "stock_news_url": "https://www.marketsmojo.com/news/pharmaids-pharmaceuticals-799751"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-May-2026",
      "details": "Newspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended March 31 2026",
      "datetime": "29-May-2026",
      "details": "The Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31 2026 at their meeting held on May 29 2026.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Audited Financial Results Along With Auditors Report For The Quarter And Year Ended 31St March 2026",
      "datetime": "29-May-2026",
      "details": "Submission of Audited Financial Results along with Auditors Report.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-06-03 10:10:33

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 03 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Are Pharmaids Pharmaceuticals Ltd latest results good or bad?

2026-06-02 19:33:55

Pharmaids Pharmaceuticals Ltd's latest financial results for Q4 FY26 reveal a complex picture of revenue growth juxtaposed against ongoing operational challenges. The company reported net sales of ₹7.18 crores, reflecting a 32.23% sequential increase from ₹5.43 crores in Q3 FY26 and a significant 50.52% rise year-on-year from ₹4.77 crores in Q4 FY25. However, this topline growth has not translated into profitability, as the company continues to face substantial net losses, with a consolidated net loss of ₹1.81 crores in Q4 FY26, which is a reduction from previous quarters but still indicative of ongoing financial distress. The operating margin for the quarter was recorded at -4.74%, an improvement from -46.04% in Q3 FY26, yet it remains firmly in negative territory. This suggests that while there has been some operational progress, the company is still grappling with structural inefficiencies that hinder i...

Read full news article

Pharmaids Pharmaceuticals Ltd Falls to 52-Week Low of Rs 25.6 as Sell-Off Deepens

2026-06-01 10:35:26

A sharp decline of 15.62% in intraday trading dragged Pharmaids Pharmaceuticals Ltd to a fresh 52-week low of Rs 25.6 on 1 Jun 2026, extending its downward trajectory amid persistent selling pressure.

Read full news article

Pharmaids Pharmaceuticals Q4 FY26: Mounting Losses Despite Revenue Growth Signal Deep Operational Crisis

2026-05-30 16:47:24

Pharmaids Pharmaceuticals Ltd., a Hyderabad-based contract research and manufacturing services company, reported its Q4 FY26 results that reveal a troubling paradox: robust revenue growth coupled with deteriorating profitability. The micro-cap pharmaceutical firm posted a consolidated net loss of ₹1.81 crores for the March 2026 quarter, marking a 27.02% sequential decline and a 54.06% year-on-year deterioration, even as net sales surged 50.52% YoY to ₹7.18 crores.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-05-22 10:10:58

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 22 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-05-11 10:10:28

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-29 10:10:36

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-18 10:10:14

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Pharmaids Pharmaceuticals Ltd is Rated Strong Sell

2026-04-07 10:10:02

Pharmaids Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

View All News